P1.13-06 First-Line Lorlatinib Versus Crizotinib for Advanced Anaplastic Lymphoma Kinase-Positive (ALK+) Non-Small Cell Lung Cancer.

Details

Language :

English

ISSN :

15560864

Volume :

13

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

132779080

Full Text :

https://doi.org/10.1016/j.jtho.2018.08.863